STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Ainos Form 4 shows 50,000-share special stock award to director

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ainos, Inc. (AIMD) reported an insider equity award to one of its directors. On November 25, 2025, the reporting person received a grant of 50,000 shares of common stock as special stock awards, which were granted and vested on the same date at a reported price of $2.10 per share. These awards had been approved by Ainos stockholders on November 7, 2025.

Following this transaction, the director beneficially owns 101,546 shares of Ainos common stock in direct ownership. The filing also shows related movements in derivative securities (RSUs) that correspond to the 50,000 underlying common shares, with the RSU position moving to zero after conversion into common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
chang wen-han

(Last) (First) (Middle)
8880 RIO SAN DIEGO DRIVE
SUITE 800

(Street)
SAN DIEGO CA 92108

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ainos, Inc. [ AIMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 11/25/2025 A 50,000(1) A $2.1 101,546 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RSU (1) 11/25/2025 A 50,000 (1) (1) Common Stock 50,000 (1) 0 D
RSU (1) 11/25/2025 C 50,000 (1) (1) Common Stock 50,000 (1) 0 D
Explanation of Responses:
1. Reference is made to the 50,000 shares of common stock granted and vested to the Reporting Person as special stock awards on November 25, 2025. The special stock awards have been approved by the stockholders of Ainos, Inc. on November 7, 2025.
/s/ Chun-Hsien Tsai by POA for Wen-Han Chang 11/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ainos (AIMD) report in this Form 4?

Ainos (AIMD) reported that a director received 50,000 shares of common stock as special stock awards on November 25, 2025, which were granted and vested on that date.

At what price were the 50,000 Ainos (AIMD) shares recorded in the Form 4?

The 50,000 Ainos common shares in the reported transaction are shown with a price of $2.10 per share.

How many Ainos (AIMD) shares does the reporting person own after this transaction?

After the reported transaction, the director beneficially owns 101,546 shares of Ainos common stock in direct ownership.

What was the nature of the equity award reported by Ainos (AIMD)?

The filing describes the grant as special stock awards of 50,000 shares of common stock to the reporting person, granted and vested on November 25, 2025.

Were Ainos (AIMD) stockholders involved in approving this special stock award?

Yes. The 50,000-share special stock awards were approved by the stockholders of Ainos, Inc. on November 7, 2025.

What does the Form 4 show about Ainos (AIMD) RSUs held by the director?

Table II shows 50,000 RSUs tied to Ainos common stock that were acquired and then converted, with the number of derivative securities beneficially owned reported as 0 after the transaction.

Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

10.15M
1.66M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO